CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 4 Exercise or conversion Director acquired 732 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 732 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 15,000 shares at an average $110.92 ($1,663,855)
- 4 Planned sale Director sold 15,000 shares at an average $108.32 ($1,624,836)
- 4 Planned sale Director sold 15,000 shares at an average $103.38 ($1,550,703)
- 4 Planned sale President sold 15,000 shares at $105.02 ($1,575,300)
- 4 Planned sale Director sold 15,000 shares at an average $107.12 ($1,606,865)
- 4 Planned sale Chief Financial Officer sold 705 shares at $101.93 ($71,859)
- 4 Planned sale Director sold 15,000 shares at an average $101.68 ($1,525,268)
- 4 Planned sale Director sold 15,000 shares at an average $109.06 ($1,635,864)
- 4 Planned sale Director sold 15,000 shares at an average $102.39 ($1,535,820)
- 4 Planned sale President sold 15,000 shares at $103.17 ($1,547,550)
- 4 Planned sale Director sold 15,000 shares at an average $108.54 ($1,628,031)
- 4 Planned sale Chief Legal Officer sold 544 shares at $99.05 ($53,884)
Page 9 of 54 · 1,067 filings